Elixinol Wellness Ltd
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Elixinol Wellness Limited functions as a dedicated health and wellness enterprise, engaged in the creation and supply of a broad spectrum of plant-based and hemp-derived products. These offerings include nutraceuticals, advanced skincare, and various food items. The company showcases a comprehensive brand portfolio featuring Elixinol for its cannabidiol (CBD) range, alongside Hemp Foods Australia, Mt Elephant, The Healthy Chef, and Field Day, addressing human nutrition, overall wellness, and pet supplementation needs. Its distribution network extends across Australia, the Americas, Europe, and other international territories, leveraging grocery, wholesale, and expanding e-commerce platforms. Founded in 2017, the company, formerly known as Elixinol Global Limited, adopted its current name, Elixinol Wellness Limited, in May 2021. Based in South Melbourne, Australia, it recently reported an 81% surge in group revenue for 2024, attributed to strategic acquisitions and operational enhancements, with further plans for growth in e-commerce and the healthy snacking sector throughout 2025.
Company News
Elixinol Wellness Limited (ELLXF) Shareholder/Analyst Call Prepared Remarks Transcript
Elixinol Wellness Limited (ELLXF) Discusses New National Distribution Agreement and Capital Structure Reset Transcript
Elixinol Wellness Limited (ELLXF) Q4 2025 Earnings Call Transcript
Elixinol Wellness Limited (OTCMKTS:ELLXF) Short Interest Update
Study on the safety of Elixinol Hemp Extract is published in Journal of Toxicology
Elixinol Wellness strikes deal with British Cannabis to continue distribution in the UK
Elixinol Wellness well-funded over next 18 months to take advantage of improving outlook across key markets
Elixinol Wellness delivers best EBITDA and earnings since first half 2019
Elixinol Wellness returns to growth in June quarter as it seeks to expand existing markets and new growth drivers
Elixinol Wellness and CannaCare Health terminate acquisition as changing German market dynamics threaten returns
Elixinol Wellness in trading halt with an announcement related to proposed acquisition pending
Elixinol Wellness and Health House International unite with medicinal cannabis distribution agreement
Elixinol Wellness Makes Key Appointments To Leadership Team
Elixinol Global sees steady improvements in first quarter revenue as UK COVID restrictions ease and US stimulus packages take effect
Elixinol Global's products pass key administrative check by Food Standards Agency and can remain for sale in UK market
Elixinol to Acquire 100% of CannaCare Health
Elixinol Global positions itself as a leading pan-European CBD company by acquiring Germany's CannaCare Health
Elixinol Global in trading halt with potential transaction news pending
Elixinol Global accelerates growth strategy following global re-set of initiatives
Elixinol Global substantial holder Regal Funds Management increases stake